Showing results (81-90 of 131) with videos related to
Sort By:
Pageof 14
European Journal of Medicinal Chemistry|March 12, 2019
Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2Lei Wang, Pascale Coric, Sylvain Broussy, et al.Cellular Signalling|September 2, 2008
Capns1, a new binding partner of RasGAP-SH3 domain in K-Ras(V12) oncogenic cells: modulation of cell survival and migrationPerayot Pamonsinlapatham, Brunilde Gril, Sylvie Dufour, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2011
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasmaLionel Faivre, Charline Gomo, Olivier Mir, et al.Ebiomedicine|November 4, 2025
Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patientsBlaise Pasquiers, Benoit Blanchet, Xavier Puéchal, et al.Plos One|June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinomaOlivier Mir, Romain Coriat, Benoit Blanchet, et al.Pharmacological Research|July 6, 2016
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patientsAlicja Puszkiel, Mélanie White-Koning, Nicolas Dupin, et al.Cytometry. Part B, Clinical Cytometry|September 18, 2014
Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standardsLionel Faivre, Lucie Lecouflet, Wang-Qing Liu, et al.Targeted Oncology|May 21, 2017
Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated MelanomaFanny Garlan, Benoit Blanchet, Nora Kramkimel, et al.Chemmedchem|October 28, 2010
Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agentsRaphaël Labruère, Benoît Gautier, Marlène Testud, et al.Journal of Medicinal Chemistry|May 14, 2010
Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonistBenoit Gautier, Victor Goncalves, Donatella Diana, et al.Pageof 14